AU741713B2 - Modulation of human mast cell activation - Google Patents
Modulation of human mast cell activation Download PDFInfo
- Publication number
- AU741713B2 AU741713B2 AU70985/98A AU7098598A AU741713B2 AU 741713 B2 AU741713 B2 AU 741713B2 AU 70985/98 A AU70985/98 A AU 70985/98A AU 7098598 A AU7098598 A AU 7098598A AU 741713 B2 AU741713 B2 AU 741713B2
- Authority
- AU
- Australia
- Prior art keywords
- purinoceptor
- mast cells
- agent
- atp
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4146197P | 1997-03-25 | 1997-03-25 | |
| US60/041461 | 1997-03-25 | ||
| PCT/US1998/005922 WO1998042353A1 (en) | 1997-03-25 | 1998-03-24 | Modulation of human mast cell activation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU7098598A AU7098598A (en) | 1998-10-20 |
| AU741713B2 true AU741713B2 (en) | 2001-12-06 |
Family
ID=21916643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU70985/98A Ceased AU741713B2 (en) | 1997-03-25 | 1998-03-24 | Modulation of human mast cell activation |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6372724B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1011686B9 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2001518118A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE470441T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU741713B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2288821C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69841711D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1011686T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998042353A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2288821C (en) * | 1997-03-25 | 2008-10-14 | Allegheny University Of The Health Sciences | Modulation of human mast cell activation |
| DK1187617T3 (da) * | 1999-06-18 | 2004-04-13 | Alcon Mfg Ltd | Fremgangsmåde til at vælge koncentrationen af et amfipatisk antihistaminlægemiddel ved at bestemme lægemidlets overfladeaktivitetsmåltal |
| GB9916757D0 (en) | 1999-07-17 | 1999-09-15 | Glaxo Group Ltd | Method |
| EP1269198A2 (en) * | 2000-03-23 | 2003-01-02 | Novartis AG | Identification of mast/basophil activation inhibitors |
| US20040072865A1 (en) * | 2001-01-15 | 2004-04-15 | Bouillot Anne Marie Jeanne | Aryl piperidine derivatives as inducers of ldl-receptor expression |
| JP2004520347A (ja) * | 2001-01-15 | 2004-07-08 | グラクソ グループ リミテッド | Ldl−受容体発現のインデューサーとしてのアリールピペリジンおよびピペラジン誘導体 |
| EP1351937A1 (en) * | 2001-01-15 | 2003-10-15 | Glaxo Group Limited | Aryl piperidine derivatives as inducers of ldl-receptor expression |
| MXPA04004215A (es) * | 2001-11-06 | 2004-07-08 | Inspire Pharmaceuticals Inc | Metodo para el tratamiento o la prevencion de enfermedades inflamatorias. |
| WO2003070902A2 (en) * | 2002-02-20 | 2003-08-28 | Incyte Corporation | Receptors and membrane-associated proteins |
| US20070276126A1 (en) * | 2002-08-13 | 2007-11-29 | Incyte Corporation | Cell adhesion and extracellular matrix proteins |
| US20070219353A1 (en) * | 2002-09-03 | 2007-09-20 | Incyte Corporation | Immune Response Associated Proteins |
| AU2003279829A1 (en) * | 2002-10-04 | 2004-05-04 | Incyte Corp | Protein modification and maintenance molecules |
| AU2003300785A1 (en) * | 2002-11-12 | 2004-06-03 | Incyte Corporation | Carbohydrate-associated proteins |
| AU2003295462A1 (en) * | 2002-11-13 | 2004-06-03 | Incyte Corporation | Lipid-associated proteins |
| AU2003302234A1 (en) * | 2002-11-26 | 2004-06-18 | Incyte Corporation | Immune response associated proteins |
| WO2004098539A2 (en) | 2003-04-30 | 2004-11-18 | Incyte Corporation | Kinases and phosphatases |
| WO2006012639A2 (en) * | 2004-07-22 | 2006-02-02 | Duska Scientific Co. | Method of diagnosing, monitoring and treating pulmonary diseases |
| EP1910535B1 (en) | 2005-06-24 | 2016-08-17 | The Walter And Eliza Hall Institute Of Medical Research | Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| GB0601058D0 (en) * | 2006-01-19 | 2006-03-01 | Univ Southampton | Mast Cell Carboxypeptidase As A Marker For Anaphylaxis And Mastocytosis |
| CA2680801A1 (en) * | 2007-03-14 | 2008-09-18 | Sierra Molecular Corporation | Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule |
| US10517839B2 (en) * | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
| US10107795B2 (en) | 2012-10-25 | 2018-10-23 | The United States Of America As Represented By The Department Of Veterans Affairs | Composition and methods for the prevention and treatment of diet-induced obesity |
| US10614684B2 (en) | 2017-01-31 | 2020-04-07 | The United States Government As Represented By The | Treatment of kidney diseases associated with elevated AVP |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5733916A (en) * | 1995-03-24 | 1998-03-31 | The Trustees Of The University Of Pennsylvania | Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53148539A (en) * | 1977-05-30 | 1978-12-25 | Fujisawa Pharmaceut Co Ltd | Antiallergic agnet |
| US5158940A (en) * | 1990-02-14 | 1992-10-27 | The United States Government As Represented By The Secretary, Dhhs | Use of suramin to treat rheumatologic diseases |
| US5504090A (en) * | 1994-03-30 | 1996-04-02 | Trustees Of The University Of Pennsylvania | Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury |
| EP0760850A1 (en) * | 1994-05-27 | 1997-03-12 | Glaxo Group Limited | P2x RECEPTORS (PURINOCEPTOR FAMILY) |
| US5874420A (en) | 1995-12-26 | 1999-02-23 | Allegheny University Of The Health Sciences | Process for regulating vagal tone |
| CA2288821C (en) * | 1997-03-25 | 2008-10-14 | Allegheny University Of The Health Sciences | Modulation of human mast cell activation |
-
1998
- 1998-03-24 CA CA002288821A patent/CA2288821C/en not_active Expired - Fee Related
- 1998-03-24 WO PCT/US1998/005922 patent/WO1998042353A1/en not_active Ceased
- 1998-03-24 AU AU70985/98A patent/AU741713B2/en not_active Ceased
- 1998-03-24 AT AT98917959T patent/ATE470441T1/de active
- 1998-03-24 DE DE69841711T patent/DE69841711D1/de not_active Expired - Lifetime
- 1998-03-24 US US09/381,692 patent/US6372724B1/en not_active Expired - Fee Related
- 1998-03-24 EP EP98917959A patent/EP1011686B9/en not_active Expired - Lifetime
- 1998-03-24 JP JP54597398A patent/JP2001518118A/ja not_active Ceased
- 1998-03-24 DK DK98917959.3T patent/DK1011686T3/da active
-
2001
- 2001-12-20 US US10/027,052 patent/US6465441B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5733916A (en) * | 1995-03-24 | 1998-03-31 | The Trustees Of The University Of Pennsylvania | Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE470441T1 (de) | 2010-06-15 |
| WO1998042353A1 (en) | 1998-10-01 |
| US6465441B2 (en) | 2002-10-15 |
| US6372724B1 (en) | 2002-04-16 |
| EP1011686B9 (en) | 2011-02-09 |
| EP1011686B1 (en) | 2010-06-09 |
| JP2001518118A (ja) | 2001-10-09 |
| EP1011686A4 (en) | 2003-03-19 |
| CA2288821A1 (en) | 1998-10-01 |
| AU7098598A (en) | 1998-10-20 |
| DE69841711D1 (de) | 2010-07-22 |
| DK1011686T3 (da) | 2010-10-11 |
| US20020055515A1 (en) | 2002-05-09 |
| CA2288821C (en) | 2008-10-14 |
| EP1011686A1 (en) | 2000-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2288821C (en) | Modulation of human mast cell activation | |
| Carsetti et al. | Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases | |
| Willis et al. | Release and actions of prostaglandins in inflammation and fever: inhibition by anti-inflammatory and antipyretic drugs | |
| Partida-Sánchez et al. | Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity | |
| Wilson et al. | Adenosine receptors and asthma | |
| Botta Gordon‐Smith et al. | Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis | |
| Davoine et al. | Expression of FcγRIII (CD16) on human peripheral blood eosinophils increases in allergic conditions | |
| Powers et al. | Selective inhibition of functional lymphocyte subpopulations by ribavirin | |
| Gabriella Matera et al. | New treatments for COPD in the elderly | |
| Frangova et al. | BAL neutrophilia in asthmatic patients: a by-product of eosinophil recruitment? | |
| Arm et al. | Expression of complement receptors type 1 (CR1) and type 3 (CR3) on circulating granulocytes in experimentally provoked asthma | |
| Boogaerts et al. | In vitro modulation of normal and diseased human neutrophil function by pentoxifylline | |
| Okuda et al. | Histamine release from human leukocytes by platelet-activating factor | |
| Stosic-Grujicic et al. | Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin | |
| Suwaki et al. | Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug | |
| Gentile et al. | The relationship between airway hyperreactivity (AHR) and sodium, potassium adenosine triphosphatase (Na+, K+ ATPase) enzyme inhibition | |
| Bruijnzeel et al. | Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes | |
| Kadioglu et al. | Steroid pulse therapy for rheumatoid arthritis: effect on lymphocyte subsets and mononuclear cell adhesion. | |
| Walker | Effects of adenosine on guinea pig pulmonary eosinophils | |
| WO1995010287A1 (en) | Substituted purine nucleoside analogs and method for treating endotoxin shock | |
| Thomé et al. | Nicotine alters the ectonucleotidases activities in lymphocytes: In vitro and in vivo studies | |
| Abrams et al. | Cytotoxic T lymphocyte-induced loss of target cell adhesion and lysis involve common and separate signaling pathways. | |
| Fadal | The immunobiology and immunopharmacology of the allergic response | |
| DuBuske | Introduction: Mediator Assays and Inflammatory Events in Asthma and Allergic Disease:(Immunology Research Institute of New England Symposium) | |
| Lemanske | Late-phase pulmonary reactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: DR. AMIR PELLEG, EDWARD S. SCHULMAN Free format text: THE FORMER OWNER WAS: ALLEGHENY UNIVERSITY OF THE HEALTH SCIENCES |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: DUSKA SCIENTIFIC CO. Free format text: FORMER OWNER WAS: DR. AMIR PELLEG, EDWARD B SCHULMAN |